Ryan Heslin retweeted
Pleased to announce as of next week that I will be joining @NateraOncology as a medical director in GI oncology.
I’m grateful for the 8 years at UTSW and the opportunity to grow as a GI oncologist. Looking forward to advancing the science of MRD and precision onc in GI cancers
Ryan Heslin retweeted
Single-stage laparoscopic common bile duct exploration (#LCBDE) reduced costs and length of stay vs ERCP plus cholecystectomy, with improved net margin in #choledocholithiasis care. ja.ma/4xMEC5m
Ryan Heslin retweeted
Charting the future of the field, strong work @HHuanglab and friends
Impressive review in @Cancer_Cell from an impressive set of authors:
Molecular phenotypes and spatial archetypes: A new framework for cancer-associated fibroblasts
cell.com/cancer-cell/fulltex…
@IamLinghua @HHuanglab @MaraShermanLab @shouval @BiffiGiulia
Ryan Heslin retweeted
End to an incredible run in Dallas. Thanks for everything @UTSW_Surgery
This is what it's all about. Celebrating @ZachWhitham402 CGSO match to MD Anderson for fellowship. @UTSW_Surgery @utswcancer
Excited to see this published! The review team at @JAMAOnc was incredible and made this manuscript significantly better.
Had a great time working with @ZachWhitham402 @MPettigrewMD @SamWangMD @Alex_Kim_HIPEC and the entire team. @UTSW_Surgery @UTSWSurgeryLife @utswcancer
Among patients with early age–onset #ColorectalCancer in Texas, treatment delays longer than six weeks were associated with reduced survival, and language barriers represented a major risk factor contributing to delayed initiation of definitive therapy. ja.ma/43bcZoB
Ryan Heslin retweeted
Among patients with early age–onset #ColorectalCancer in Texas, treatment delays longer than six weeks were associated with reduced survival, and language barriers represented a major risk factor contributing to delayed initiation of definitive therapy. ja.ma/43bcZoB
Ryan Heslin retweeted
Treatment Delays in Early Age–Onset Colorectal Cancer.
jamanetwork.com/journals/jam…
@JAMA_current @JAMANetwork @JAMAOnc
#ColonCancer #crcsm #CancerResearch
@utswcancer @UTSW_Surgery @UTSWMedCenter
Ryan Heslin retweeted
Matthew Porembka, M.D., has been selected as Section Head of HPB/Upper GI Surgery within the Division of Surgical Oncology. His leadership, clinical expertise & dedication to advancing patient care continue to make a lasting impact on our department & the patients we serve.
Ryan Heslin retweeted
Excited to share that I will be joining Atrium Health & Advocate Health as Division Chief of Surgical Oncology, inaugural Richard L. White Jr. Endowed Professor of Surgery at Wake Forest University School of Medicine, and Surgeon-in-Chief Atrium Health Levine Cancer in Charlotte, North Carolina. I will also have the privilege to serve in the Scientific Committee of IRCAD-North America.
Thankful to @BrentDMatthews , Dr. Ruben Mesa @mpdrc, Eugene Woods for their trust and support.
I welcome the challenges and opportunities ahead: to build at scale, expand access to complex cancer care, and integrate surgery, innovation, technology, and research across a multistate system. @LevineCancer @AtriumHealth @advocatehealth @wakeforestmed
Eternally grateful for the mentors, colleagues, and trainees who shaped this journey 🙏
🤖 Made with AI
Ryan Heslin retweeted
Great paper @ZhiVenFongMD!
@SkylarNahiMD @MPorembka just reported our @UTSW_Surgery experience with robot completion CCY. bit.ly/4cwiu5y
21 cases in past 3 yrs. 35 months was median interval from initial CCY to reoperation. All completed robotically, 70% same day d/c. 1 patient with major complication (IR drain for abscess). 🤖is definitely the way for these cases!
@herbert_zeh @PatricioPolanc0 @AdamYopp
🧵1/
Your partner sees a pt who has remnant cholecystitis s/p a subtotal CCY last year, and laments that this is an epidemic of the push for more subtotals as a bailout.
We explore this question in our article in @acsJACS & 🧵below.
journals.lww.com/journalacs/…
Ryan Heslin retweeted
This past weekend we hosted our 3rd Annual Pancreatic Cancer Symposium @utswcancer with an amazing keynote speaker @KarynAGoodman All the talks by the interdisciplinary faculty were exceptional. Thank you to all the faculty, attendees, community physicians partners, patients, patient advocates & industry sponsors that participated. @UTSWMedCenter @UTSW_Surgery @UTSWHemeOnc
Ryan Heslin retweeted
Congratulations on the newest Surgeons to our Family! #UTSWIsBest
Ryan Heslin retweeted
Congratulations to @NFatimahMD on giving a great talk for her best paper award at @SocSurgOnc #SSO2026. Did a great job representing @UTSW_Surgery and @utswcancer!
Ryan Heslin retweeted
Clinically localized gastric cancer has about 40% chance of occult peritoneal metastases. Staging laparoscopy is NOT optional. Glad to have @SamWangMD @MPorembka and others on our multi-d team rapidly taking these pts to the OR for accurate staging
Underutilization of Staging Laparoscopy Prior to Neoadjuvant Systemic Therapy in Gastric Cancer. @AnnSurgOncol link.springer.com/article/10…
Ryan Heslin retweeted
A meaningful moment at Advanced Cancer Therapies today as we announced the new David L. Bartlett Legacy Award. This award will honor lasting contributions to our field, with the first recipient to be named in 2027. #ACT2026
Ryan Heslin retweeted
Have you ever wondered why do large (>3cm) & Mixed Type IPMNs have a higher risk of invasive neoplasia and carcinoma?
In these @JAMASurgery & @acsJACS publications led by @amudhan_kannan for our research group we attempt to decipher the biological behavior of IPMN using NGS
Ryan Heslin retweeted
A substantial proportion of admitted surgical patients used a patient portal for real-time result and note viewing in the wake of the 21st Century Cures Act. ja.ma/45MuQnU

















































